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To the Editor:
We read with interest the article by
Lei and associates1 on palliative arte-
rial switch for transposition of the
great arteries, ventricular septal de-
fect, and pulmonary vascular obstruc-
tive disease. We agree with them that
the palliative arterial switch operation
is definitely a better option than the
palliative atrial switch operation. At
our institution, we have performed 3
such operations in the past 2 years
with a different approach. In these 3
patients, aged 1.5 years, 4.5 years,
and 11 years, we used a simplified
unidirectional-valved patch to close
the ventricular septal defect (VSD).
The surgical technique of construction
of this patch was described in detail by
us earlier.2 All 3 of these patients had
severe pulmonary arterial hyperten-
sion with pulmonary artery systolic
pressures of 110 mm Hg, 126 mm
Hg, and 110 mmHg with a pulmonary
vascular resistance of 9.5 units, 7
units, and 17.1 units, respectively. In-
traoperative transesophageal echocar-
diography was used to see the
direction of shunting across the patch
after termination of cardiopulmonary
bypass. In all 3 patients there was ev-
idence of right-to-left shunt through
the valved patch with mild systemic
desaturation. Postoperative recovery
was uneventful in all 3 patients except
for episodic systemic desaturation in
the first 2 patients, which was docu-
mented on echocardiography to be
due to right-to-left shunt across the848 The Journal of Thoracic and Cpatch. The current follow-up of these
patients is 3 months, 1 year, and 1
month, respectively, and these pa-
tients have systemic saturation in
excess of 95% with no right-to-left
shunting across the patch. The second
patient had a cardiac catheterization 8
months after the operation, and the
pulmonary artery systolic pressure
has fallen to 49 mm Hg.
On the basis of our small experi-
ence with this technique, we believe
that a unidirectional-valved patch
may be a better alternative to an
open or partially closed VSD. The ob-
vious advantage is that a repeat inva-
sive procedure to close the VSD is
avoided. Moreover, this strategy also
avoids the costs of a repeat cardiac
catheterization and the substantial
cost of the device used to close the
VSD. In many parts of the world,
these are important considerations.
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We read with interest the letter to
the Editor by Talwar, Choudhary,
and Airan on palliative arterial switch
for transposition of the great arteries,
ventricular septal defect, and pulmo-
nary vascular obstructive disease.
We appreciate the insightful contribu-
tion of their experience with
unidirectional-valved patch to close
the ventricular septal defect (VSD)ardiovascular Surgery c March 2011in 3 patients, with apparently satisfac-
tory short to midterm outcomes (mean
follow-up of 5.3 months). The ratio-
nale for this approach is obviously
an attempt to save the patients from
the additional financial burden of
future device closure of the VSD.
Although patients with VSDs pre-
senting late for surgical closure with
moderate-to-severe PVOD are rare in
developed countries, they account for
a significant percentage of our patient
population in China (possibly the
same in other developing countries),
and we do have rather extensive expe-
rience with unidirectional-valved
patch closures of VSDs in this unique
patient population in the 1990s. What
we found was that if there was no per-
sistent or intermittent right-to-left
shunt at theventricular level, the unidi-
rectional valvewould be stuck and per-
manently closed within a relatively
short period of time (a few weeks to
a few months). In our article, 50% of
our survivors (9/18) had persistent or
even progressive PVOD up to 4 years
of mean follow-up time. When these
patients have occasional exacerbation
of their pulmonary hypertension with
suprasystemic right ventricular pres-
sure, their VSD fenestrations become
their only way of survival. With recent
domestic production of the Amplatzer
occluder device in China, the cost of
transcatheter VSD device closure has
fallen markedly. In our opinion, fenes-
trated VSD closure in this patient pop-
ulation confers a higher postoperative
safety index with a small price to pay.
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